Skip to main content
1-877-936-8422
VICC
Search
Main navigation
Home
Patient Care
Cancer Care Overview
Find a Doctor
Request an Appointment
Find a Clinical Trial
MyHealth at Vanderbilt
Support & Education
Cancer Information
Clinical Trials
Clinical Trials Overview
Frequently Asked Questions
Trial Search for Physicians
Trial Search For Patients
Flowcharts
Research
Research Overview
Research Programs
Shared Resources
Clinical Trials
Member Directory
Membership Information
Funding Opportunities
Seminars & Lectures
Giving
Giving & Impact
Make a Gift
Donor-Supported Research
Volunteer
Community
Community Overview
Advocacy
VICC Ambassadors
Education
Education, Training, and Career Development
Annual Scientific Retreat
About
About Vanderbilt-Ingram
Leadership
Fast Facts
History
Careers
For Media
More
Intranet (for faculty and staff)
About the site
Help
Contact the web team
Prices
Search
at Vanderbilt-Ingram Cancer Center
Site Search
All
Pages
Members
Clinical Trials
News
975 results found
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
Relevance:
1
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
Relevance:
1
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Relevance:
1
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Relevance:
1
Testing the use of AMG 510 (Sotorasib) and Panitumumab as a Targeted Treatment for KRAS G12C Mutant Solid Tumor Cancers (A ComboMATCH Treatment Trial)
Relevance:
1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With Select Solid Tumors
Relevance:
1
Phase 1b Combo w/ Ribociclib and Alpelisib
Relevance:
1
ILND Surgery Alone or after Chemotherapy with or without Radiation Therapy in Treating Patients with Advanced Penile Cancer
Relevance:
1
Study of INBRX-109 in Conventional Chondrosarcoma
Relevance:
1
Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma
Relevance:
1
Pagination
Previous page
‹ previous
…
Page
90
Page
91
Page
92
Page
93
Page
94
Page
95
Current page
96
Page
97
Page
98
Next page
next ›